Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biofrontera Inc. Completes $4.2 Million Private Placement of Senior Secured Convertible Note Quiver Quantitative, Inc. - Fri Nov 22, 6:24PM CST

Biofrontera completes a $4.2 million secured convertible note private placement to support operations and growth initiatives.Quiver AI SummaryBiofrontera Inc. has announced the completion of a $4.2 million...

BFRI : 0.8700 (+14.62%)
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note GlobeNewswire - Fri Nov 22, 8:10AM CST

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Reports Third Quarter 2024 Financial Results Amid Hurricane Impact and Positive Product Developments Quiver Quantitative, Inc. - Thu Nov 14, 2:56AM CST

Biofrontera reported Q3 2024 revenues of $9 million, affected by Hurricane Milton, with notable Ameluz sales growth and FDA approval.Quiver AI SummaryBiofrontera Inc. reported total revenues of $9.0 million...

BFRI : 0.8700 (+14.62%)
Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update GlobeNewswire - Wed Nov 13, 4:15PM CST

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) GlobeNewswire - Thu Oct 31, 9:32AM CDT

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) GlobeNewswire - Mon Oct 14, 9:30AM CDT

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment GlobeNewswire - Mon Oct 7, 7:45AM CDT

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand FinancialNewsMedia - Tue Oct 4, 2022

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...

PIXY : 6.53 (-14.30%)
EW : 70.48 (+0.14%)
BFRI : 0.8700 (+14.62%)
LITE : 89.09 (+4.06%)
CUTR : 0.3166 (+0.19%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand PR Newswire - Tue Oct 4, 2022

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

PIXY : 6.53 (-14.30%)
EW : 70.48 (+0.14%)
BFRI : 0.8700 (+14.62%)
LITE : 89.09 (+4.06%)
CUTR : 0.3166 (+0.19%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH Globe Newswire - Mon Aug 1, 2022

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot